University Hospitals Birmingham NHS Foundation Trust

Loading results...
View full results list

Medicines A–Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

A

Status	Drug name	NICE TAs	Comments
	Ascorbic acid tablets
	Asfotase alfa		NHSE commissioned
	Asparaginase 10,000 units injection (5 vials)
	Aspirin 300mg dispersible tablets		Topical analgesia - for gargling
	Aspirin dispersible tablets
	Aspirin suppositories
	Atenolol tablets
	Atezolizumab (Tecentriq®)	TA739 - Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable TA823: Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer
	Atezolizumab (Tecentriq®)	TA492 - Atezolizumab for untreated PD-L1-positive locally advanced or metastatic urothelial cancer when cisplatin is unsuitable TA520 - Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy TA525 - Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy TA333 - Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment TA584 - Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer TA639 - Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer TA638 - Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer TA666 - Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma TA705 - Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer	Hospital use only
	Atomoxetine		ESCAs and additional advice in relation to age of patient and CCG

Building healthier lives